+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunofixation"

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
2024 Global Immunoassay Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, 2023-2028 - Product Thumbnail Image

2024 Global Immunoassay Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • February 2024
  • Japan, United States, ... Japan, United States, Europe, Global
From
From
Loading Indicator

Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis. The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more